PRESS RELEASE published on 08/05/2025 at 09:05, 1 year 3 months ago BioNxt Solutions Reports Pending Patent Grants in Europe and Eurasia, Strengthening IP Protection for Proprietary Sublingual Cladribine-Based MS Treatment BioNxt Solutions Inc. makes significant progress in global patent portfolio with EPO and EAPO confirming acceptance of core claims for sublingual Cladribine thin-film formulation. Focus on innovation in MS treatment BioNxt Solutions Inc. Patent Portfolio Cladribine EPO EAPO
BRIEF published on 07/26/2025 at 00:05, 1 year 3 months ago BioNxt Solutions Closes First Tranche of Debenture Placement Private Placement Warrants Convertible Debentures Product Development BioNxt Solutions
BRIEF published on 07/26/2025 at 00:05, 1 year 3 months ago BioNxt Solutions clôture la première tranche de son placement d'obligations Obligations Convertibles Placement Privé Développement De Produits Mandats Solutions BioNxt
PRESS RELEASE published on 07/26/2025 at 00:00, 1 year 3 months ago BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement BioNxt Solutions Inc. closes first tranche of non-brokered private placement, raising $1,009,200 for drug delivery tech and IP development. Securities subject to statutory hold until Nov 26, 2025 Private Placement Convertible Debentures BioNxt Solutions Inc. Intellectual Property Drug Delivery Technologies
BRIEF published on 07/23/2025 at 09:10, 1 year 3 months ago BioNxt Advances Cladribine Thin-Film Development Multiple Sclerosis Cladribine Drug Delivery BioNxt Solutions Sublingual Thin-Film
BRIEF published on 07/23/2025 at 09:10, 1 year 3 months ago BioNxt fait progresser le développement de couches minces de cladribine Sclérose En Plaques Cladribine Solutions BioNxt Administration De Médicaments Film Mince Sublingual
PRESS RELEASE published on 07/23/2025 at 09:05, 1 year 3 months ago BioNxt Delivers Positive Results in Patented Cladribine Sublingual Thin-Film Program and Completes Successful Formulation BioNxt Solutions Inc. announces successful development of sublingual thin-film prototype for cladribine-based drug delivery in multiple sclerosis treatment, strengthening clinical development path BioNxt Solutions Inc. Cladribine Drug Delivery Multiple Sclerosis Treatment Thin-film Prototype
BRIEF published on 07/12/2025 at 00:05, 1 year 3 months ago BioNxt Solutions Proposes Convertible Debenture Unit Offering Private Placement Convertible Debenture Investor Information Product Development BioNxt Solutions
BRIEF published on 07/12/2025 at 00:05, 1 year 3 months ago BioNxt Solutions propose une offre d'unités d'obligations convertibles Placement Privé Développement De Produits Informations Pour Les Investisseurs Obligation Convertible Solutions BioNxt
PRESS RELEASE published on 07/12/2025 at 00:00, 1 year 3 months ago BioNxt Solutions Announces Convertible Debenture Unit Private Placement BioNxt Solutions Inc. announces $1.2M non-brokered private placement of convertible debenture units for product development and commercialization Private Placement Convertible Debentures BioNxt Solutions Inc. Commercialization Product Development
Published on 11/10/2026 at 02:45, 2 hours 34 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:00, 6 hours 19 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 6 hours 47 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 7 hours 4 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 04:55, 23 minutes ago The 19th Europe-China Business and Technology Cooperation Fair boosts business cooperation
Published on 11/10/2026 at 01:20, 3 hours 58 minutes ago US defence customer steps up orders and first graphene oxide orders secured
Published on 11/09/2026 at 22:54, 6 hours 24 minutes ago EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Published on 11/09/2026 at 22:10, 7 hours 8 minutes ago Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
Published on 11/09/2026 at 18:30, 10 hours 49 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 10 hours 49 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 11 hours 34 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 11/09/2026 at 17:45, 11 hours 34 minutes ago Déclaration des droits de vote à fin octobre 2026